Biomimetic Responsive Nanoconverters with Immune Checkpoint Blockade Plus Antiangiogenesis for Advanced Hepatocellular Carcinoma Treatment-Reference-Cited by-同舟云学术

Biomimetic Responsive Nanoconverters with Immune Checkpoint Blockade Plus Antiangiogenesis for Advanced Hepatocellular Carcinoma Treatment

Published:2024-02-02 Issue:6 Volume:16 Page:6894-6907
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Zhang Yuting¹²,Zhong Aoxue²,Min Juan³,Tu Haibin²,Cao Yanbing²,Fu Jinghao²,Li Yonghao²,Liu Xiaolong²^ORCID,Yang Yong⁴,Wang Jianmin¹⁴,Liu Jingfeng¹²⁴,Wu Ming²^ORCID

Affiliation:

1. Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, P. R. China

2. The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China

3. Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, P. R. China

4. Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, P. R. China

Funder

Medical Innovation Project of Fujian Province

Scientific Foundation of Fujian Province

Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province

Scientific Foundation of Fuzhou Municipal Health Commission

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.3c18140

Reference54 articles.

1. Hepatocellular carcinoma

2. Hepatocellular carcinoma

3. Hepatocellular Carcinoma

4. Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

5. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prussian blue nanoparticle-based pH-responsive self-assembly for enhanced photothermal and chemotherapy of tumors;Journal of Photochemistry and Photobiology B: Biology;2024-07